The Toxic Effect and Mechanism of TMZ Combined with siHOXB9 on Glioblastoma Cells
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms27010079 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Xiaoyu Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical Science and Engineering, Beijing Jiaotong University, Beijing 100091, China. Hauptthemen laut MEDLINE: Temozolomide, Glioblastoma, Homeodomain Proteins, RNA, Small Interfering. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Natural Science Foundation.
Abstract (Originalsprache)
Glioblastoma (GBM) represents a highly invasive primary malignant tumor within the central nervous system (CNS). Temozolomide (TMZ), a first-line chemotherapy agent for GBM treatment, has significant limitations, including drug resistance, poor water solubility, a short half-life, and notable toxic side effects. The innovation of the TMZ dosage form is pivotal for enhancing its therapeutic efficacy. In this study, solid lipid nanoparticles (SLN) loaded with Angiopep-2 (A2) and TMZ (TMZ-A2SLN), a nanopolymer featuring a solid spherical morphology and a particle size of approximately 100 nm, were constructed. The combined effect of TMZ-A2SLN and small-interfering RNA (siRNA) that can knock down the expression of the HOXB9 gene (siHOXB9) augmented the sensitivity of the glioma cell line U251 to TMZ. Under the combined effect, the viability of U251 cells was reduced by 77%. Meanwhile, the mortality rate increased by approximately 45%, and the cell apoptosis rate rose by around 36%. The number of cells arrested in the G2/M and S phases rose. Proteomic analysis indicates that TMZ-A2SLN might be implicated in the pro-inflammatory signaling cascade, tumor migration, invasion, and angiogenesis during the treatment of glioma cells. Moreover, HOXB9 may play a crucial regulatory role in the PPAR signaling pathway, the neural signaling pathway, the phospholipase D signaling pathway, the IL-17 signaling pathway, mineral absorption, and other pathways during glioma cell treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physical Science and Engineering, Beijing Jiaotong University, Beijing 100091, China.
ORCID-Profile: Yunfei Liu, Qianwen Wang, Xiyu Cheng
Förderung
- Beijing Natural Science Foundation
Zitieren
APA
Liu, X., Liu, Y., Li, W., Wang, Q., Huang, Z., Cheng, X., Yan, Q., & Hu, H. (2025). The Toxic Effect and Mechanism of TMZ Combined with siHOXB9 on Glioblastoma Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27010079
Vancouver
Liu X, Liu Y, Li W, Wang Q, Huang Z, Cheng X, et al. The Toxic Effect and Mechanism of TMZ Combined with siHOXB9 on Glioblastoma Cells. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms27010079
BibTeX
@article{Liu2025,
author = {Liu, Xiaoyu and Liu, Yunfei and Li, Wenxuan and Wang, Qianwen and Huang, Ziyu and Cheng, Xiyu and Yan, Qiong and Hu, Honggang},
title = {The Toxic Effect and Mechanism of TMZ Combined with siHOXB9 on Glioblastoma Cells},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms27010079}
}
EUVIMED